首页> 外文OA文献 >Corrigendum to 'Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial' [Vaccine 35 (2017) 395-402].

【2h】

Corrigendum to 'Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial' [Vaccine 35 (2017) 395-402].

机译：更正“在12、18或24个月加强接种4CMenB疫苗后的持久性杀菌抗体，以及在4岁时（第三阶段扩展至随机对照试验）给予第五剂的免疫原性” [疫苗35（2017）395-402] 。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Iro, MA; Snape, MD; Voysey, M; Jawad, S; Finn, A; Heath, PT; Bona, G; Esposito, S; Diez-Domingo, J; Prymula, R; Odueyungbo, A; Toneatto, D; Dull, P; Pollard, A; European Men B Vaccine Study Group;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献

1. Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial [J] . SnapeM.D., PhilipJ., JohnT.M., The Pediatric infectious disease journal . 2013,第10期

机译：在6、8、12个月使用2种研究性B组脑膜炎双球菌疫苗免疫后2年的杀菌抗体持久性和学前加强剂量的免疫原性：一项针对随机临床试验的后续研究
2. Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines [J] . Vesikari Timo, Forsten Aino, Bianco Veronique, The Pediatric infectious disease journal . 2015,第12期

机译：初次接种四年后使用相同疫苗接种的四价脑膜炎球菌ACWY-破伤风类毒素共轭疫苗与单价脑膜炎球菌血清C组疫苗加强剂量的免疫原性，安全性和抗体持久性
3. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial [J] . Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Wedoc Vaccine . 2019,第35期

机译：伴随婴儿脑膜炎球菌血群B（4cmeNb）疫苗携带的肺炎球菌非型血液渗透蛋白D族蛋白D缀合物（PhID-CV）的免疫原性：在第3B期，随机，受控试验中的HOC分析
4. Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose [O] . Matthew D. Snape, Praveen Saroey, Tessa M. John, 2013

机译：婴儿早期接种B群脑膜炎球菌疫苗后的杀菌抗体的持久性和学前加强剂量的免疫原性
5. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial [O] . Iro Mildred A., Snape Matthew D., Voysey Merryn, 2017

机译：在第12、18或24个月加强接种4CMenB疫苗后的杀菌抗体的持久性，以及在4岁时进行的第五次剂量的免疫原性-延长至随机对照试验的第3期

Corrigendum to 'Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial' [Vaccine 35 (2017) 395-402].

著录项

相似文献

相关主题

期刊订阅